Orion Corporation (pharmaceutical company)

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 88.115.251.5 (talk) at 10:09, 21 December 2015 (Added a few OTC medications to the list.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Orion Oyj
Company typeJulkinen osakeyhtiö
Nasdaq HelsinkiORNBV
IndustryPharmaceutical industry
Founded1917
HeadquartersEspoo, Finland
Key people
Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
ProductsPharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue€1006.9 million (2013)[1]
€267.7 million (2013)[2]
€206.2 million (2013)[3]
Total assets€979.0 million (2013)[4]
Total equity€513.9 million (2013)[5]
Number of employees
3,519 (2013)[6]
Websitewww.orion.fi

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion's class A and B shares are listed on the Helsinki Stock Exchange.

Products

  • Cardiovascular drugs

References

External links